REFERENCES
- Mudd SH, Harvey LL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989: 693–734.
- Refsum H, Ueland PM, Nygard 0, Wollset SE. Homocysteine and cardiovascular disease. Ann Rev Med 1998; 49: 31–62.
- Hultberg B, Agardh E, Andersson A, Brattsrom L, Isaksson A, Israelsson B, Agardh C-D. Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 1991; 51: 277–82.
- Agardh C-D, Agardh E, Andersson A, Hultberg B. Lack of association between plasma homo-cysteine levels and microangiopathy in type I diabetes mellitus. Scand J Clin Lab Invest 1994; 54: 637–41.
- Hultberg B, Agardh C-D, Agardh E, Lövestam-Adrian M. Poor metabolic control, early age at onset, and marginal folate deficiency are asso-ciated with increasing levels of plasma homo-cysteine in insulin-dependent diabetes mellitus. A five-year follow-up study. Scand J Clin Lab Invest 1997; 57: 595–600.
- Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmol 1991; 98: 766–85.
- Andersson A, Isaksson A, Brattstrom L, Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 1993; 39: 1590–97.
- Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent dia-betes mellitus. N Engl J Med 1993; 329: 977–86.
- Feener PE, King GL. Vascular dysfunction in diabetes mellitus. Lancet 1997; 350 Suppl I: 9–13.
- Loscalzo J. The oxidant stress of hyperhomocys-t(e)inemia. J Clin Invest 1996; 98: 5–7.
- Stamler JS, Osborne JA, Jaraki 0, Mullins M, Single D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308–11.
- Tsai JC, Wang H, Perella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang THTC, Schlegel R, Lee ME. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest 1996; 97: 146–53.
- Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP. Hyperhomocyst(e)inemia and endothelial dysfunc-tion in IDDM. Diabetes Care 1998; 21: 841–8.
- Bostom A, Brosnan JT, Hall B, Nadeau MR, Selhub J. Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 1995; 116: 59 — 62.
- Chico A, Perez A, Córdoba A, Arcelüs R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998; 41: 684— 93.
- Agardh C-D, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabet Comp 1992; 6: 96— 100.
- Moslkalets E, Galstyan G, Starostina E, Antisiferov M, Chantelau E. Association of blindness to intensification of glycemic control in insulin-dependent diabetes mellitus. J Diabet Comp 1994; 8: 45–50.
- Lövestam-Adrian M, Agardh E, Agardh C-D. The temporal development of retinopathy and nephro-pathy in type 1 diabetes mellitus during 15 years diabetes duration. Diabet Res Clin Pract 1999; 45: 15–23.
- Agardh E, Tallroth G, Bauer B, Cavallin-Sjoberg U, Agardh C-D. Retinopathy and nephropathy in insulin-dependent diabetics: an inconsistent relationship? Diabet Med 1987; 4: 248–50.
- Lövestam-Adrian M, Agardh E, Agardh C-D. The incidence of nephropathy in type 1 diabetic patients with proliferative retinopathy: a 10-year follow-up study. Diabet Res Clin Pract 1998; 39: 11 — 7.